J. Casey McGlynn

WSGR Partner

J. Casey McGlynn is Chairman of the Life Sciences Group at Wilson Sonsini Goodrich and Rosati, a nationally recognized leader in the representation of startup and emerging growth companies in the life sciences field. Mr. McGlynn has one of the largest practices in the country focused on Medical Devices.

Mr. McGlynn has formed, sold and taken public many of the most important medical device companies started during the last 25 years. These companies include Anatros Corporation (predecessor to Tyco's IV business), Advanced Cardiovascular Systems and Devices for Vascular Interventions (predecessors to Guidant's vascular business), Aneurx (predecessor to Medtronic's Aortic Aneurism business), Arthrocare (ARTC), Biopsys Medical (predecessor to JNJ's women's health business), Cardiac Pathways (predecessor to BSX's atrial fibrillation business), Cardiothoracic Systems (predecessor to Guidant's cardiac surgery business), Conor MedSystems (CONR), Cutera (CUTR), CVIS (predecessor to BSX's vascular ultrasound business), FoxHollow Technologies (FOXH), Fusion Medical (predecessor to Baxter's surgical sealant business), HeartStream (predecessor to Phillips' external defibrillator business), Perclose (predecessor to Abbott's vascular business), Somnus Medical (predecessor to Gyrus' ENT business), Spinal Concepts (predecessor to Abbott's orthopedics business), Ventana Medical Systems (VMSI), and Ventritex (predecessor to St Jude's CRM business).

Mr. McGlynn has extensive hands on experience in helping entrepreneurs form, build, fund and sell their companies. He has formed, participated with the boards of and invested in companies in all of the major Medical Device fields, including biologics, cancer, cardiovascular, cardiac surgery, congestive heart failure, cosmetic medicine, diagnostics, electrophysiology, ENT, gastroenterology, general surgery, hearing, imaging, monitoring, neurosurgery, obesity, ophthalmology, orthopedics, peripheral vascular disease, renal therapy, sports medicine, urology, and women's health. Over the last 25 years he has built close working relationships with an unparalleled list of entrepreneurs, doctors, investors, engineers, and managers in this industry. Through his portfolio of companies he has met with and negotiated with the leaders of all of the major Medtech acquirers.

During the past 10 years Mr. McGlynn has participated in forming and managing several funds all of which have been top quartile performers. Mr. McGlynn is also the founder of Life Science Angels, an angel organization focused on early stage medtech and biotech investments. Mr. McGlynn is a director of several private medtech companies and the Medical Device Manufacturers Association, a Washington trade association for early stage medtech companies.